Studies have explored the potential role of DNA-PKcs in multiple tumors, and showed that DNA-PKcs could regulate AKT-mammalian target of rapamycin (mTOR) activation, thus regulating in cancer survival, proliferation and resistance to radiation/chemotherapy12, 13, 16, 17, 18. This evidence concerns the gene PRKDC and cancer.